We have now reached 10% of the funding goal for the historical mTOR inhibitor screening project! The purpose with the project is to discover even more effective mTOR inhibitors than Rapamycin when it comes to extending lifespan. If you’re passionate about longevity or simply want

Time for an update of Aubrey de Grey’s great longevity study (RMR 1). The main goal with the RMR study design is to speed up the discovery of interventions that increase both median and maximum lifespan with at least 40% in middle-aged mice. The below toplist is sorted by what

We’ve achieved 30% of our funding goal for the groundbreaking mTOR inhibitor screening project! The purpose with this project is to uncover even more potent mTOR inhibitors than Rapamycin when it comes to extending lifespan. If you’re enthusiastic about longevity or want to make

This is the poster that I plan to put up at the biggest longevity conference ARDD now at the end of August in Copenhagen. It's a quite good summary of the upcoming white paper for the mTOR inhibitor screening project that I'm project leading. What do you think?

Don't miss out the free webinar where the results from the largest Rapamycin trial, the PEARL trial, will be revealed. I would argue that this trial is a big milestone and something most people in the longevity field should have a look at. I'm very curious to see the results.

What a great ARDD conference! Here are Rapamycin key highlights from it. ✅ Linda Partridge: Has discovered that combining Rapamycin and Trametinib result in good lifespan effects in both mice and flies. Next step is clinical trials to see if this translates to humans. ✅

Rapamycin Longevity Lab has made an interesting experiment with the Ora Biomedical's WormBot-AI technology. The lab has pushed the median lifespan above the 50% line by combining the PI3K/mTOR inhibitor GSK2126458, a new longevity compound Rapamycin Longevity Lab discovered